| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |